Dipeptidyl peptidase IV (DPP4) Activity Assay Kit (Fluorometric)
Be the first to review this product! Submit a review
|
(7 Publications)
Dipeptidyl peptidase IV (DPP4) Activity Assay Kit ab204722 is an assay where DPP4 cleaves a substrate to release a quenched fluorescent group, AMC (7-Amino-4-Methyl Coumarin), which can be easily detected at Ex/Em = 360/460 nm.
Individual kit components also available for purchase with a minimum order of 20 units. Contact us to discuss your needs.
View Alternative Names
CD26, ADCP2, DPP4, Dipeptidyl peptidase 4, ADABP, Adenosine deaminase complexing protein 2, Dipeptidyl peptidase IV, T-cell activation antigen CD26, TP103, ADCP-2, DPP IV
- FuncS
Supplier Data
Functional Studies - Dipeptidyl peptidase IV (DPP4) Activity Assay Kit (Fluorometric) (AB204722)
Typical AMC Standard calibration curve.
- FuncS
Supplier Data
Functional Studies - Dipeptidyl peptidase IV (DPP4) Activity Assay Kit (Fluorometric) (AB204722)
Dipeptidyl peptidase IV (DPP4) Positive Control.
Reactivity data
Product details
Dipeptidyl peptidase IV (DPP4) Activity Assay Kit (Fluorometric) (ab204722) is an assay where DPP4 cleaves a substrate to release a quenched fluorescent group, AMC (7-Amino-4-Methyl Coumarin), which can be easily detected at Ex/Em = 360/460 nm. This assay is rapid, simple, sensitive, and reliable, as well as, suitable for high throughput activity screening of DPP4. This kit detects DPP4 activity as low as 3 uU per well.
DPP4 assay protocol summary:
- add samples and standards to wells
- add reaction mix
- analyze with microplate reader for 30 min in kinetic mode
Other Notes
This product was previously called K779 Biovision DPP4 Activity Fluorometric Assay Kit. Biovision was acquired by Abcam in 2021.
Dipeptidyl peptidase-4 (DPP4), also known as adenosine deaminase complexing protein 2 or CD26 (cluster of differentiation 26) is a protein that, in humans, is encoded by the DPP4 gene. The substrates of CD26/DPP4 are proline (or alanine) containing peptides and include growth factors, chemokines, neuropeptides, and vasoactive peptides. DPP4 plays a major role in glucose metabolism. It is responsible for the degradation of incretins such as GLP-1 and hence its inhibition by drugs such as Sitagliptin have been used for treatment of diabetes mellitus type 2. DPP4 also appears to work as a suppressor in the development of cancer and tumors.
The standard is affinity purified.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
DPP4 plays a significant role in glucose metabolism and immune function. The enzyme interacts with members of the immune system and regulates proteins such as chemokines growth factors and neuropeptides. DPP4 acts independently and is not known to be part of a larger complex. It modulates biological processes by inactivating peptide hormones and signaling molecules which impacts glucose homeostasis and immune responses.
Pathways
DPP4 impacts the incretin signaling pathway and the immune response pathway. Incretin hormones like glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are substrates of DPP4 and play important roles in glucose metabolism. DPP4 also interacts with proteins such as adenosine deaminase (ADA) which impacts T-cell function and immune regulation. The regulation of these pathways by DPP4 influences metabolic and immune health.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Stem cell research & therapy 13:357 PubMed35883204
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed35456981
2022
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 16:e0252153 PubMed34043673
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nutrients 13: PubMed33808180
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancer research 79:735-746 PubMed30584072
2018
Applications
Unspecified application
Species
Unspecified reactive species
Kidney & blood pressure research 43:987-999 PubMed29913457
2018
Applications
Unspecified application
Species
Unspecified reactive species
Diabetes 67:518-531 PubMed29254987
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com